Non-Hodgkin's lymphomas, version 1.2013. uri icon

Overview

abstract

  • These NCCN Guidelines Insights summarize several key updates to the NCCN Guidelines for Non-Hodgkin's Lymphomas (NHL) and provide a discussion of the clinical evidence that support the updates. The updates discussed in this article feature recommendations for additional treatment options in patients with chronic lymphocytic leukemia and guidance surrounding the management of hepatitis virus reactivation/infections in high-risk patients with NHL undergoing antitumor therapy.

authors

  • Zelenetz, Andrew
  • Wierda, William G
  • Abramson, Jeremy S
  • Advani, Ranjana H
  • Andreadis, C Babis
  • Bartlett, Nancy
  • Bellam, Naresh
  • Byrd, John C
  • Czuczman, Myron S
  • Fayad, Luis E
  • Glenn, Martha J
  • Gockerman, Jon P
  • Gordon, Leo I
  • Harris, Nancy Lee
  • Hoppe, Richard T
  • Horwitz, Steven Michael
  • Kelsey, Christopher R
  • Kim, Youn H
  • Krivacic, Susan
  • LaCasce, Ann S
  • Nademanee, Auayporn
  • Porcu, Pierluigi
  • Press, Oliver
  • Pro, Barbara
  • Reddy, Nishitha
  • Sokol, Lubomir
  • Swinnen, Lode
  • Tsien, Christina
  • Vose, Julie M
  • Yahalom, Joachim
  • Zafar, Nadeem
  • Dwyer, Mary A
  • Naganuma, Maoko

publication date

  • March 1, 2013

Research

keywords

  • Lymphoma, Non-Hodgkin

Identity

Scopus Document Identifier

  • 84875888445

Digital Object Identifier (DOI)

  • 10.6004/jnccn.2013.0037

PubMed ID

  • 23486452

Additional Document Info

volume

  • 11

issue

  • 3